Relation between BMD and biochemical, transfusion and endocrinological parameters in pediatric thalassemic patients

Fariba Mohseni1, Mohammad Reza Mohajeri-Tehrani, Bagher Larijani

  • 1Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Insights

Pediatric beta-thalassemia major patients often experience low bone density and short stature. Early monitoring in late childhood and early teenage years is recommended for these complications.

Area of Science:

  • Pediatric Endocrinology
  • Hematology
  • Bone Metabolism

Background:

  • Beta-thalassemia major is associated with low bone mineral density (BMD) and increased fracture risk.
  • Endocrinological and biochemical parameters are often affected in these patients.

Purpose of the Study:

  • To investigate the relationship between BMD and various biochemical, transfusion, and endocrinological parameters in pediatric beta-thalassemia major patients.
  • To identify the prevalence of complications such as short stature, hypogonadism, subclinical hypothyroidism, and impaired fasting glucose.

Main Methods:

  • A cohort of 30 pediatric beta-thalassemia major patients (14 males, 16 females) was studied.
  • Data collected included demographic, anthropometric, and medical histories, alongside serum levels of key biochemical and hormonal markers.
  • Bone mineral density (BMD) of the spine and femur was assessed using dual-energy X-ray absorptiometry (DXA).

Main Results:

  • Prevalence rates were observed for low spinal BMD (3.3%), low femoral BMD (10%), short stature (33%), hypogonadism (16.6%, exclusively in boys), subclinical hypothyroidism (6.6%), and impaired fasting glucose (26.6%).
  • Age and transfusion duration showed positive correlations with both spinal and femoral BMD, but negative correlations with their respective Z-scores.
  • Patients with short stature and hypogonadism were significantly older than their counterparts.

Conclusions:

  • Age is a primary factor associated with reduced bone mineral density Z-scores in pediatric beta-thalassemia major.
  • The findings underscore the importance of early and regular monitoring for endocrine and growth-related complications in these patients during late childhood and early adolescence.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
3.0K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.0K
Blood Typing01:10

Blood Typing

Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
5.9K